Blood substitute resuscitation as a treatment modality for moderate hypovolemiaCHEUNG, Anthony T. W; DRIESSEN, Bernd; JAHR, Jonathan S et al.Artificial cells, blood substitutes, and biotechnology. 2004, Vol 32, Num 2, pp 189-207, 19 p.Article

Efficacy of a new blood substitute based on ultra-pure polymerized bovine hemoglobulin. A preliminary reportVLAHAKES, G. J; LEE, R; JACOBS, E. E et al.European journal of cardio-thoracic surgery. 1989, Vol 3, Num 4, pp 353-354, issn 1010-7940Conference Paper

Blood substitutes: why haven't we been more successful?ALAYASH, Abdu I.Trends in biotechnology (Regular ed.). 2014, Vol 32, Num 4, pp 177-185, issn 0167-7799, 9 p.Article

Proceedings/3th international symposium on «blood substitutes», 1987, Montreal, PQ, CANCHANG, T. M. S; GEYER, R.Biomaterials, artificial cells and artificial organs. 1988, Vol 16, Num 1-3, issn 0890-5533, XVII-703 pConference Proceedings

Substituts sanguins. Préparation et étude in vivo de solutions d'hémoglobine pyridoxylée-polymérisée = Blood substitutes. Preparation and study in vivo of pyridoxylated and polymerized hemoglobin solutionsCLERC, Y; DUBOS, M; DELAMOURD, L et al.Médecine et armées. 1987, Vol 15, Num 5, pp 419-422, issn 0300-4937Article

7.5% Saline and 7.5% Saline/6% Dextran for Hypovolemic ShockBULGER, Eileen M.The Journal of trauma, injury, infection, and critical care. 2011, Vol 70, Num 5, issn 1079-6061, S27-S29, SUPConference Paper

Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an exampleCHANG, Thomas Ming Swi.Artificial cells, blood substitutes, and biotechnology. 2006, Vol 34, Num 6, pp 551-566, 16 p.Conference Paper

Oxidative mechanisms of hemoglobin-based blood substitutesALAYASH, Abdu I.Artificial cells, blood substitutes, and immobilization biotechnology. 2001, Vol 29, Num 6, pp 415-425, issn 1073-1199Article

Artificial bloodSQUIRES, Jerry E.Science (Washington, D.C.). 2002, Vol 295, Num 5557, issn 0036-8075, 1002,1004-1005 [3 p.]Article

International symposium on red cell substitutesBiomaterials, artificial cells and artificial organs. 1989, Vol 17, Num 5, pp 617-705, issn 0890-5533Article

Dextran 40 therapy made safer by pretreatment with dextran 1LJUNGSTRÖM, Karl-Gösta.Plastic and reconstructive surgery (1963). 2007, Vol 120, Num 1, pp 337-340, issn 0032-1052, 4 p.Article

Blood substitutes based on nanobiotechnologyCHANG, Thomas Ming Swi.Trends in biotechnology (Regular ed.). 2006, Vol 24, Num 8, pp 372-377, issn 0167-7799, 6 p.Article

Abstracts from the VIIIth International Symposium on Blood SubstitutesArtificial cells, blood substitutes, and immobilization biotechnology. 2001, Vol 29, Num 2, issn 1073-1199, 98 p.Conference Proceedings

A potential blood substitute from a tetronic polyol and a modified hemoglobinCERNY, L. C; CERNY, E. L; LISCZYNSKJ, M et al.Biomaterials, artificial cells, and immobilization biotechnology. 1992, Vol 20, Num 1, pp 71-93, issn 1055-7172Article

Pyridoxylated polymerized hemoglobin solution processing. Interest of a membrane molecular fractionation stepCLERC, Y; DUBOS, M; BIHOREAU, N et al.Applied biochemistry and biotechnology. 1987, Vol 14, Num 3, pp 241-251, issn 0273-2289Article

Microbial dextran-hydrolyzing enzymes : Fundamentals and applicationsKHALIKOVA, Elvira; SUSI, Petri; KORPELA, Timo et al.Microbiology and molecular biology reviews. 2005, Vol 69, Num 2, issn 1092-2172, 22 p., 192-193, 306-325 [22 p.]Article

Untersuchungen zum rheologischen Verhalten von Blutersatzmitteln auf Perfluorcarbonbasis = Studies of the rheological behaviour of blood substitutes on a perfluorocarbon baseDRAFFEHN, J; REICHELT, H.Pharmazie. 1991, Vol 46, Num 11, pp 800-802, issn 0031-7144Article

A comparison of the doppler spectra from human blood and artificial blood used in a flow phantomHOSKINS, P. R; LOUPAS, T; MCDICKEN, W. N et al.Ultrasound in medicine & biology. 1990, Vol 16, Num 2, pp 141-147, issn 0301-5629Article

MP4, a new nonvasoactive PEG-Hb conjugateVANDEGRIFF, Kim D; MALAVALLI, Ashok; WOOLDRIDGE, Jerod et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 4, pp 509-516, issn 0041-1132, 8 p.Article

Perfluorocarbons as oxygen-transport fluidsLOWE, K. C.Comparative biochemistry and physiology. A. Comparative physiology. 1987, Vol 87, Num 4, pp 825-838, issn 0300-9629Article

Pharmacokinetic Study of Enclosed Hemoglobin and Outer Lipid Component after the Administration of Hemoglobin Vesicles as an Artificial Oxygen CarrierTAGUCHI, Kazuaki; URATA, Yukino; OTAGIRI, Masaki et al.Drug metabolism and disposition. 2009, Vol 37, Num 7, pp 1456-1463, issn 0090-9556, 8 p.Article

Relationship between the protein surface hydrophobicity and its partitioning behaviour in aqueous two-phase systems of polyethyleneglycol-dextranTUBIO, Gisela; NERLI, Bibiana; PICO, Guillermo et al.Journal of chromatography. B. 2004, Vol 799, Num 2, pp 293-301, issn 1570-0232, 9 p.Article

Médicaments dérivés du plasma et hémostase : actualités, perspectivesSTV. Sang thrombose vaisseaux. 2001, Vol 13, Num MAR, issn 0999-7385, 103 p., NSConference Proceedings

Preparation of highly purified hemoglobin by affinity elutionHONG XUE; HUI ZHENG; WU, X.-F et al.Artificial cells, blood substitutes, and immobilization biotechnology. 1998, Vol 26, Num 3, pp 317-327, issn 1073-1199Article

Blood substitutesTSUCHIDA, E; CHANG, T. M. S; SEKIGUCHI, S et al.Artificial cells, blood substitutes, and immobilization biotechnology. 1998, Vol 26, Num 5-6, issn 1073-1199, 264 p.Conference Proceedings